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Abstract
Background: Sandhoff disease is a lysosomal storage disorder characterized by the absence of b-hexosaminidase and
storage of GM2 ganglioside and related glycolipids. We have previously found that the progressive neurologic disease
induced in Hexb
2/2 mice, an animal model for Sandhoff disease, is associated with the production of pathogenic anti-
glycolipid autoantibodies.
Methodology/Principal Findings: In our current study, we report on the alterations in the thymus during the development
of mild to severe progressive neurologic disease. The thymus from Hexb
2/2 mice of greater than 15 weeks of age showed a
marked decrease in the percentage of immature CD4
+/CD8
+ T cells and a significantly increased number of CD4
+/CD8
2 T
cells. During involution, the levels of both apoptotic thymic cells and IgG deposits to T cells were found to have increased,
whilst swollen macrophages were prominently observed, particularly in the cortex. We employed cDNA microarray analysis
to monitor gene expression during the involution process and found that genes associated with the immune responses
were upregulated, particularly those expressed in macrophages. CXCL13 was one of these upregulated genes and is
expressed specifically in the thymus. B1 cells were also found to have increased in the thy mus. It is significant that these
alterations in the thymus were reduced in FcRc additionally disrupted Hexb
2/2 mice.
Conclusions/Significance: These results suggest that the FcRc chain may render the usually poorly immunogenic thymus
into an organ prone to autoimmune responses, including the chemotaxis of B1 cells toward CXCL13.
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Introduction
Lysosomal storage disorders (LSDs) arise from functional defects
inoneormore oftheproteinsessentialtonormallysosomefunction.
This typically involves the enzymes that play a critical role in the
intracellular digestion of glycoproteins, glycolipids, glycosaminogly-
cans, or other macromolecules [1]. GM2 gangliosidoses, one of the
major LSDs, are caused by an abnormality in the b-hexosamini-
dases [1,2]. b-Hexosaminidase A consists of a heterodimer of an a-
subunit (HEXA gene product) and a b-subunit (HEXBgene product)
whereas b-Hexosaminidase B is a homodimer of b-subunits.
Mutations in the HEXA gene cause Tay-Sachs disease, whereas
mutations in the HEXB gene cause Sandhoff disease (SD) [1].
Previous studies have shown that the Hexb-deficient (Hexb
2/2)
mouse develops an SD-like illness and therefore provides a useful
animal model for investigating the pathophysiology of SD [3–5]. As
with many of the other LSDs, neurodegeneration is a prominent
feature of SD and since the neurons accumulate a large amount of
GM2 ganglioside and GA2 relative to other tissues in this disease, it
is generally thought that the nervous system is its main pathological
target. The accumulation of GM2 ganglioside or its derivatives in
the nervous system is implicated in unscheduled neuronal cell death
[6]. However, recent studies have provided good evidence that
GM2 ganglioside and GA2 accumulation can not account for all of
the nervous system damage in Hexb
2/2 mice.
For example, bonemarrow transplantation from normal(Hexb
+/+)
to Hexb
2/2 mice suppresses neuronal death and improves survival
ratios despite having no effect on either b-hexosaminidases activities
or ganglioside accumulation in the brain [7–9].
We have reported in a previous study that an autoimmune
response occurs in Hexb
2/2 mice with accompanying pathophys-
iological phenotypes [10]. To determine the role of anti-
ganglioside autoantibodies in this earlier study, we additionally
disrupted the Fc receptor gamma (FcRc) gene in the Hexb
2/2
mouse model, as it plays a key role in immune complex-mediated
autoimmune diseases. Clinical symptoms were improved and life
spans were extended in the resulting double-null (Hexb
2/2FcRc
2/2)
mice, suggesting that autoantibodies play an important role in the
central nervous system (CNS) pathophysiology in SD. Moreover, we
found that age-matched Hexb
2/2FcRc
2/2 mice had a reduced serum
titer of anti-GA2 autoantibody when compared with Hexb
2/2
FcRc
+/+ mice, suggesting that the FcRc dependent pathway(s) also
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12105contribute to the production of autoantibodies [10]. Recently also,
autoantibodies have been implicated in several LSDs and their
respective mouse models such as MPSIIIB [11], Batten disease
[12–15], and Gaucher disease [16,17]. This suggests that the
production of autoantibodies is mediated by common pathway(s)
among these diseases although the underlying mechanism of
production remains unknown.
The thymus is a central or primary lymphoid organ responsible
for the production, differentiation and direction of a population of
small lymphocytes that are involved primarily with cell-mediated
immunity. Such thymus-dependent lymphocytes are known as T-
lymphocytes in contrast to the bone marrow dependent B-
lymphocytes with which they intimately co-operate. Recently,
alterations in the thymus were observed in several LSD model
animals such as feline GM1 gangliosidosis [18–20], and twitcher
mice [21]. In Hexb
2/2 mice, GM2 and GA2 were found to have
accumulated in the thymus [22]. Impaired selection of invariant
natural killer T cells was also observed in this same study [22].
However, whether such alterations in the thymus contribute to the
LSD pathophysiology remains unknown.
Over the last decade, a family of chemotactic cytokines known as
the chemokines has been found to be involved in the trafficking of
leukocytes in both normal and pathological states. Several
autoimmune diseases, such as rheumatoid arthritis, systemic lupus
erythematosus, multiple sclerosis, and myasthenia gravis, are
associated with inappropriate activation of the chemokine network
[23]. For example, aberrant high expression of Chemokine (C-X-C
motif)ligand 13(CXCL13) inthethymusinaged (NZB6NZW) F1
(BWF1) mice may play a pivotal role in breaking immune tolerance
in the thymus and in recruiting autoantibody-producing B1 cells
and CD4
+T cells during the development of murine lupus [24–26].
B1 cells of different origin and function than conventional B cells
(B2 cells) have long been considered to be involved in autoantibody
production in autoimmune diseases [27–29].
In Hexb
2/2 mice, cDNA microarray analysis of the CNS has
previously revealed an upregulation of inflammatory cytokines/
chemokines including CXCL13, dominated by activated microg-
lia/macrophages [8]. The expected mechanism underlying this
microglia/macrophage activation was the storage of glycolipids
from engulfed apoptotic neurons. Normally, most T cells are
eliminated within the cortex or at the cortico-medullary junction
via programmed cell death. These T cells are usually rapidly
engulfed by macrophages without accompanying immune activa-
tion. It is thus possible that if the macrophages cannot degrade
apoptotic T cell-derived glycolipids, they are also activated.
We hypothesize that the thymus plays an important role in the
production of autoantibodies in SD. We have therefore examined the
thymic alterations of Hexb
2/2 mice during the development of mild to
severe progressive neurologic disease in our current study and explored
the relationship between these thymic abnormalities and autoimmunity.
Results
Hexb
2/2FcRc
+/+ mice develop progressive and age-
related thymus atrophy
Our initial analysis indicated that Hexb
2/2FcRc
+/+ mice with
clinically severe neurologic signs had a severely reduced thymic
mass (Fig. 1A). In comparison, age-matched Hexb
2/2FcRc
2/2
mice had only a slight reduction in their thymic mass. To evaluate
whether these thymic alterations were due to hypoplasia or
premature involution, thymic tissues from younger mice were also
examined quantitatively. A comparison of Hexb
+/2FcRc
+/+,
Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 thymic weights is shown
in Figure 1B. The 15 week old Hexb
2/2FcRc
+/+ mice showed
significant (75%) loss of thymic weight when compared with age-
matched Hexb
+/2FcRc
+/+ mice. In contrast, there were no
significant differences between the younger mice of both
genotypes. Hexb
2/2FcRc
2/2 mice had a slight, but statistically
significant, reduction in thymic weight when compared with
Hexb
+/2FcRc
+/+ mice. Flow cytometric analysis further revealed
that CD4
+/CD8
+ immature T cell ratio was dramatically
decreased in the 15 week old Hexb
2/2FcRc
+/+ thymus compared
with that of the Hexb
+/2FcRc
+/+ mice (5.8% vs. 88.0%), whereas
the CD4
+/CD8
2 and CD4
2/CD8
+ T cell ratios were markedly
increased (Fig. 1C top panel). Moreover, the CD4
2/CD8
2 non T
cell population ratio was also increased in Hexb
2/2FcRc
+/+ mice.
In Hexb
2/2FcRc
2/2 mice, the percentages of CD4
+/CD8
+,
CD4
+/CD8
2, CD4
2/CD8
+, and CD4
2/CD8
2 cells were
87.1%, 6.8%, 3.2%, and 2.9%, respectively. The absolute number
ofCD4
+/CD8
+T cellsperthymuswasseverelyreduced inHexb
2/2
FcRc
+/+ mice (Fig. 1C bottom panel). In addition, the absolute
number of CD4
+/CD8
2, CD4
2/CD8
+, and CD4
2/CD8
2 T cells
per thymus was also reduced in Hexb
2/2FcRc
+/+ mice.
Histological examination of the thymus from Hexb
+/2
FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice
We next undertook histological analysis of the thymic tissues
from Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2
mice. When examined by light microscopy, the histological findings
from younger Hexb
2/2FcRc
+/+ mice were found not to significantly
differ from Hexb
+/2FcRc
+/+ mice. In the 15 week old Hexb
2/2
FcRc
+/+ mice, the cellular density did not appear to be altered in the
medulla of the thymus but the cortices or cortico-medullary
junctions were frequently indistinct (Fig. 2). Moreover, many foamy
macrophages could be observed not only in the medullary area, but
also the cortex area in these mice. Some macrophages were also
found to contain hematoxylin-positive nuclear particles in their
cytoplasm. Cortices or cortico-medullary junctions were clearly
detectable in the thymus of Hexb
2/2FcRc
2/2 mice and foamy
macrophages were also present in Hexb
2/2FcRc
2/2mice. We also
examined the immunofluorescent analysis of GA2 and thymocyte, for
each thymus derived from Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and
Hexb
2/2FcRc
2/2 mice. In the 15 week old Hexb
+/2FcRc
+/+ mice,
GA2 was stained on the cellmembrane of CD4 and/or CD8 positive
T cells (Fig. S1). Age matched Hexb
2/2FcRc
+/+ mice showed the
marked decrease of the T cells in the cortex area. In contrast, GA2
was stained in those areas, and it seems to be accumulating in the
cytosol of the foamy cells. The decrease of the T cell and the
accumulation of GA2 were not more clearly observed in the
presymptomatic stage of Hexb
2/2FcRc
+/+,a n dHexb
2/2FcRc
2/2
mice. These results suggest the possibility that the localization of GA2
wasmovedfromT cellstofoamymacrophagesduring the involution.
Histological examination of a thymus from a human SD
patient
To determine whether thymic alterations can also be detected in
a human case of SD, we obtained a H&E stained tissue sample
from an SD patient for examination. The histology of this thymic
sample revealed that the cortical cells were severely reduced and
that the cortico-medullary junctions could not be clearly observed
(Fig. 3). Furthermore, most of the cortical and medullary cells
harbored a vacuolated cytoplasm.
Increased cell death in the thymus of 15 week old
Hexb
2/2FcRc
+/+ mice
The thymic tissues from 15 week old Hexb
+/2FcRc
+/+ and
Hexb
2/2FcRc
+/+ mice were further analyzed by transmission
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2/2FcRc
+/+ mice, the
macrophages contained numerous abnormal nuclear-like electron
dense particles, which were not evident in the Hexb
+/2FcRc
+/+
thymus (Fig. 4A). These macrophages were also found to contain many
vacuoles with characteristics of lysosomal storage vessels. To better
understand the progressive reduction observed in the number of
thymic cells, we analyzed thymic cell death using a TUNEL assay.
TUNEL-positive cells were more frequently found in the Hexb
2/2
FcRc
+/+ cortex and medulla than in the corresponding regions of the
Hexb
+/2FcRc
+/+ t h y m u s( F i g .4 B ) .T U N E L - p o s i t i v ep a r t i c l e sc o u l db e
seen inside the macrophages, and were thought to correspond to the
nuclear-like particles observed by TEM. We next quantified the
number of apoptotic and necrotic cells by flow cytometry. The
results showed that the numbers of AnnexinV
+/PI
2 apoptotic cells
inHexb
+/2FcRc
+/+,Hexb
2/2FcR
+/+andHexb
2/2FcR
2/2micewere
1.2860.44, 7.0662.32, and 1.7960.45 respectively. Moreover,
AnnexinV+/PI+ late apoptotic/necrotic cells were found to have
increased in the Hexb
2/2FcR
+/+ thymus (1.4760.68, 6.4561.87,
and 1.8560.69, respectively;Fig.4C). Since thymiccell death in the
Hexb
2/2FcR
2/2 mice is decreased, we hypothesized that the
immune-complex mediated response is responsible for accelerating
thymic cell death in Hexb
2/2FcR
+/+ mice. Indeed, we found a
marked increase in the percentage of IgG/TCR-(double positive T
cells(0.5360.20%vs.1.9660.67%),suggestingthat IgGisboundto
the T cell membrane, in the 15 week old Hexb
2/2FcR
+/+ mice as
compared with age-matched Hexb
+/2FcR
+/+ mice. The 15 week old
Figure 1. Hexb
2/2FcRc
+/+ mice show progressive, age-related thymus atrophy. (A) The thymus was removed from 15 week old Hexb
+/2
FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice. Scale bar, 1 cm. (B) Thymic tissues from Hexb
+/2FcRc
+/+, Hexb
2/2FcR
+/+ and Hexb
2/2FcR
2/2 mice
at 11, 13 and 15 weeks of age were removed and weighed. The data shown are expressed as the mean (S.D. of 3–14 mice for each group per time
point. *P,0.01. (C) Thymic cells from Hexb
+/2FcR
+/+, Hexb
2/2FcR
+/+ and Hexb
2/2FcR
2/2 mice were stained with CD4 and CD8 antibodies. The
percentages of T cell subsets were then determined by flow cytometry. The profiles for each genotype are indicated in the top panels. The absolute
cell numbers for each subpopulation of the thymus were calculated from the total number of thymic cells (mean (S.D.; n=3–4). *P,0.05.
doi:10.1371/journal.pone.0012105.g001
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2/2FcR
2/2 mice also showed a reduction in this population of
cells (Fig. 4D).
Macrophage activation and expansion in thymus
The swelling of macrophages is a prominent feature of many LSDs.
To confirm whether the swollen cells we observed by H&E staining of
our thymic sections were macrophages, we stained these samples with
Iba-1 and found that positive cells were rarely observed in the cortices
of the 15 week old Hexb
+/2FcR
+/+ mice. 13 week old Hexb
2/2FcR
+/+
mice were found not to significantly differ from Hexb
+/2FcRc
+/+ mice.
On the other hand, numerous Iba-1 positive swelling cells were
detected in the 15 week old Hexb
2/2FcR
+/+thymus, particularly in the
cortex. In Hexb
2/2FcR
2/2 mice, at 15 weeks of age, the numbers of
both foamy cells and amoeboid, Iba-1-positive thymic macrophages
were substantially reduced compared with the Hexb
2/2FcR
+/+ mice
(Fig. 5A). To determine whether the percentage of macrophages
among the total thymic cell population was increased, we performed
flow cytometric analysis. The percentage of thymic macrophages from
15 week old Hexb
+/2FcR
+/+, Hexb
2/2FcR
+/+ and Hexb
2/2FcR
2/2
mice was 0.9360.38, 4.3660.66 and 1.4860.25% respectively
(Fig. 5B). Recent studies have reported that the up-regulation of the
Mip-1a correlates with monocyte infiltration and the pathogenesis of
SD [30]. To quantify the increase in Mip-1a mRNA in the thymus of
15 week old Hexb
2/2FcRc
+/+ mice, the gene expression ratios of Mip-
1a relative to ribosomal protein s18 were measured by real-time RT-
PCR. A 24.6-fold increase in Mip-1a expression was detected in the
thymus of Hexb
2/2FcRc
+/+ mice in comparison with Hexb
+/2FcRc
+/+
mice. In addition, Hexb
2/2FcRc
2/2 mice showed a 2.69-fold higher
expression of Mip-1a mRNA compared with the Hexb
+/2FcRc
+/+
mice (Fig. 5C).
mRNA expression profile in the thymus of Hexb
2/2FcRc
+/+
mouse
To further elucidate the molecular basis of thymic involution,
we performed cDNA microarray analysis to identify the changes in
gene expression that accompanied the involution of the thymus.
Thymic gene expression of 15 week old Hexb
+/2FcRc
+/+ and
Hexb
2/2FcRc
+/+ mice were examined with AffymetrixH Mouse
Genome 430 2.0 Array containing 45101unique mouse gene
sequences. The gene expression profile reported in this paper has
been deposited in the Gene Expression Omnibus (GEO) database
(http://www.ncbi.nlm.nih.gov/geo: accession no. GSE19641).
8018 probes were found to be relatively increased in the thymus
of the Hexb
2/2FcRc
+/+ mice compared with that of the Hexb
+/2
FcRc
+/+ mice. On the other hand, the expression of 7604 probes
was relatively decreased. The cohort of up-regulated sequences
was dominated by genes that play a role in the immune response.
In addition, some of these genes are expressed in macrophage
Figure 2. Histological examination of the thymus from Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice. H&E staining of
paraffin-embedded thymic sections from 13 week old Hexb
+/2FcRc
+/+, 15 week old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice. The
bottom panels show a higher magnification image of the framed area in the top panels. Cor, cortex; Med, medulla. Arrows indicate vacuolated cells.
Scale bars, top panel, 100 mm; bottom panel, 50 mm.
doi:10.1371/journal.pone.0012105.g002
Figure 3. Histological examination of a thymus from an SD patient. H&E staining of a paraffin-embedded thymic section from an 11 month-
old SD patient. The right panel shows a higher magnification of the framed area in the left panel. Scale bars, left panel, 100 mm; right panel, 50 mm.
doi:10.1371/journal.pone.0012105.g003
Thymic Alterations in SD Mice
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stimulating factor 2 receptor beta 1. Th2 cytokines were mostly
upregulated in the Hexb
2/2FcRc
+/+ mice, although Th1 cytokines
did not show this increase (Table 1). In addition, B cell-related
genes such as CD19, CXCL13 were increased, whereas the T cell-
related genes were mostly decreased, in Hexb
2/2FcRc
+/+ mice
compared with Hexb
+/2FcRc
+/+ mice.
Marked increase in CXCL13 expression in the thymus of
the Hexb
2/2FcRc
+/+ mouse
Quantitative differences in CXCL13 expression in the thymus
between Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2
mice were assayed by real-time RT-PCR (Fig. 6A). There were no
significant differences found in 11 or 13 week old Hexb
+/2FcRc
+/+,
Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice. However, an
extremely high level of CXCL13 expression was observed in the
thymus of 15 week old Hexb
2/2FcRc
+/+ mice compared with the
normalized CXCL13 levels in Hexb
+/2FcRc
+/+ (23.3-fold) and
Hexb
2/2FcRc
2/2 mice. The expression of several other cytokines/
chemokines such as SDF-1 and TNF-a was not increased in
Hexb
2/2FcRc
+/+ mice compared with Hexb
+/2FcRc
+/+ mice (data
not shown). To assess whether the abnormal CXCL13 mRNA
expression is thymus-specific, we quantified the CXCL13 mRNA
levels in other lymphoid organs. The upregulation of CXCL13
was not found in the lymph nodes or spleen (Fig. 6B). In the
thymus of 15week old Hexb
2/2FcRc
+/+ mice, the normal
architecture was lost and CXCL13 was diffusely distributed
throughout the entire region (Fig. 6C). Real-time RT-PCR
analysis of magnetic cell sorted leukocyte subpopulations demon-
strated that CXCL13 is highly expressed in thymic CD11b-
positive cells, which are putatively regarded as macrophages, and
also in dendritic cells obtained from 15 week old Hexb
2/2FcRc
+/+
mice, but not in CD11b-negative cells from these animals (Fig. 6D).
The B1 and B2 cell populations are markedly increased in
the thymus of Hexb
2/2FcRc
+/+ mouse
The aberrantly high expression of CXCL13 in the thymus of
mice with murine lupus plays a pivotal role in recruiting
Figure 4. Increased cell death in the thymus of the 15 week old Hexb
2/2FcRc
+/+ mouse. (A) Thymic sections from 15 week old Hexb
2/2
FcRc
+/+ and Hexb
+/2FcRc
+/+ mice were analyzed by TEM. Left panel, at lower magnification many electron dense materials and vacuoles are evident.
Middle panel, nucleus-like electron dense particles and vacuoles are visible in the cytoplasm of the macrophages at higher magnification. Right panel,
nuclear particles were not confirmed in the thymus of the Hexb
+/2FcRc
+/+ mouse.N, nucleus particle-like structure; MN, macrophage nucleus. (B)
Paraffin-embedded thymic sections from Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice were stained using the TUNEL method. Scale bar,
50((m. A higher magnification image of the arrow position in the middle panel is shown in the right shoulder frame. (C) Thymic cells from Hexb
+/2
FcR
+/+, Hexb
2/2FcR
+/+ and Hexb
2/2FcR
2/2 mice were stained with FITC conjugated anti-Annexin V antibody and PI, and the percentages of dying
cells were determined by flow cytometry (n=4–8). *P,0.01. (D) IgG deposition in TCR(-positive T cells analyzed by flow cytometry (n=3–5). *P#0.01.
doi:10.1371/journal.pone.0012105.g004
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increased also in the thymus of 15 week old Hexb
2/2FcRc
+/+ mice.
By histological examination, we detected massive CD19-positive B
cell infiltration and/or expansion in the thymus of the 15 week old
Hexb
2/2FcRc
+/+ mice (Fig. 7A). In 13 week old Hexb
2/2FcRc
+/+
and 15 week old Hexb
2/2FcRc
2/2 mice, we did not see this B cell
expansion. The percentages of CD19
+/CD5
+/B220
lo B1 cells were
0.1260.04, 0.6860.28 and 0.2360.07% in the thymus of 15 week
old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice,
respectively, and those of CD19
+/CD5
2/B220
hi B2 cells were
0.1160.05, 0.5360.19 and 0.1760.06% respectively (Fig. 7B).
Discussion
Sandhoff disease is a lysosomal storage disorder characterized
by the absence of b-hexosaminidase and storage of GM2
ganglioside and related glycolipids. It is widely postulated that
the CNS is the main pathological target of GM2 gangliosidosis.
However, we have previously found that the production of
autoantibodies plays an important role in the pathogenesis of
neuropathy in Sandhoff disease [10]. In our present study, we
observed a dramatic involution of the thymus in 15 week old
Hexb
2/2FcRc
+/+ mouse. The thymus plays a crucial role in
immune system homeostasis, and thymic abnormalities have been
previously reported in many autoimmune diseases, such as
myasthenia gravis [31], systemic sclerosis [32], in a mouse model
of systemic lupus erythematosus [24], and multiple sclerosis [33].
Since autoimmunity is found also in SD, the contribution of
thymus abnormalities to the pathogenesis of this disease seems
plausible. We therefore tested for immunological alterations in the
thymus of Hexb
2/2FcR
+/+ mice during the development of mild to
severe progressive neurologic disease and explored the relationship
between thymic abnormalities and autoimmunity.
The thymus of the Hexb
2/2FcR
+/+ mouse was found to be
drastically involuted at the late stages, whereas this degree of
involution was reduced in the Hexb
2/2FcRc
2/2 mouse (Fig. 1A,
B), suggesting that this process is dependent on the FcR(chain. The
involution itself was found to contain a markedly decreased
Figure 5. Macrophage activation and expansion. (A) Thymic tissues from 13 week old Hexb
+/2FcR
+/+, 15 week old Hexb
+/2FcR
+/+, Hexb
2/2FcR
+/+
and Hexb
+/2FcR
+/+ mice were stained with antibodies against the macrophage marker Iba1 and processed using the avidin-biotin-peroxidase
complex (ABC) method. The bottom panels show higher magnifications of the framed areas in the top panels. Scale bars, top panel, 100(mm; bottom
panel, 50 mm. (B) Thymic cells from15 week old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice were stained with anti-Iba1 followed by
Alexa Fluor 488H conjugated anti-rabbit IgG (H+L), and the percentages of macrophages were determined by flow cytometry (n=4). *p,0.01. (C)
Mip-1a mRNA levels in the thymus from 15week old Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice were assayed by Real-time RT-PCR and these values
were compared with those of the Hexb
+/2FcRc
+/+ mouse (mean 6 S.D.; n=5–9). *P,0.05.
doi:10.1371/journal.pone.0012105.g005
Thymic Alterations in SD Mice
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increased populations of CD4+/CD8- cells, CD4-/CD8+ T cells
and CD4-/CD8- cells (Fig. 1C, top panel). The absolute number
of each subpopulation was decreased, suggesting that the changes
in cell number are strongly dependent on the decreased number of
CD4+/CD8+ T cells, rather than the increase in CD4+/CD8-
cells, CD4-/CD8+ T cells and CD4-/CD8- cells. In contrast, no
differences could be clearly observed in the younger Hexb
2/2FcR
+/+
mice. Zhou and co-workers have also shown in their previous
study that the development of classical, naive, and memory CD4
and CD8 T cells is unaffected by a Hexb deficiency [34]. The
authors did not however discuss the state of the thymus in later
stages. In other LSDs, alterations in the last stage thymus have
been previously reported in feline GM1 gangliosidosis [19,20].
Flow cytometric analyses showed a marked decrease in the
percentage of immature CD4
+/CD8
+ T cells and a significant
increase in CD4
2/CD8
+ cells in GM1 mutant cats of greater than
210daysof agewhen compared with normal age matched cats [19].
Thymic involution has also been described in twitcher mice [21]
and may therefore be a common pathological state among the
LSDs.
We next examined for histological abnormalities in the thymus
of Hexb
2/2FcRc
+/+ mice. In the 15 week old animals, the cellular
density of the thymic cortices was found to be severely reduced as
a result of a decreased number of CD4
+/CD8
+ cells (Fig. 2).
However, numerous macrophages with a ‘‘foamy’’ appearance
were found instead in this region. Some of these macrophages
contained hematoxylin-positive particles in their cytoplasm,
suggesting that the population of apoptotic thymic cells was
rapidly increased and/or that the macrophages had a diminished
phagocytic capacity. Importantly, a pathology similar to that
evident in mouse models appears to exist also in human SD (Fig. 3).
Moreover, atrophy of the thymus has previously been described in
an autopsy case report by Takahashi et al. [35], and in a personal
communication from Tatematsu et al. [36]. These observations
suggest that thymic alterations occur in SD in both mouse and
human via a common mechanism.
We next found in our mouse model that during thymic
involution, nuclear particles in the cytoplasm of the macrophages,
apoptotic thymic cells, and IgG deposition to the thymic cells were
all increased, particularly in the cortex (Fig. 4). Most thymic
lymphocytes are cleared by normal apoptotic processes but
Table 1. mRNA expression profile in the thymus of the 15 week old Hexb
2/2FcRc
+/+ mouse.
Gene name (Symbol) Base signal Exp signal Exp/Base signal Log ratio
T lymphocyte
CD3 antigen, delta (Cd3d) 4510.3 1509.6 21.6
CD4 antigen (Cd4) 1438.6 378.3 21.8
CD8 antigen, alpha chain (Cd8a) 5002.2 235.3 24.3
T-cell receptor alpha chain (Tcra) 55.1 15.1 22.1
Macrophage
Colony stimulating factor 2 receptor, beta 1 (Csfr2b1) 143 549.9 2.1
Macrophage ecpressed gene 1 (Mpeg1) 836.4 1905.2 1.3
Macrophage migration inhibitory factor (Mif) 2844.4 1810 20.6
Monocyte to macrophage differentiation-asociated (Mmd) 328.9 592.2 0.8
B lymphocyte
Early B-cell factor 1 (Ebf1) 17.9 144.5 3.1
CD79A antigen (Cd79a) 65.7 227.2 1.6
CD79B antigen (Cd79b) 155.7 407.5 1.4
CD19 antigen (Cd19) 6.7 125.3 3.8
CD38 antigen (Cd38) 167.5 497.9 1.9
Burkitt lymphoma receptor 1 (Cxcr5) 15.6 80.3 2.6
Chemokine
Chemokine (C-X-C motif) ligand 13 (Cxcl13) 29 677.1 4.6
Th2 cytokine
Interleukin 10 (Il10) 3.6 24.3 2.2
Interleukin 10 receptor, alpha (Il10ra) 49.2 118.4 1.2
Interleukin 10 receptor, beta (Il10rb) 330.8 742.2 1.3
Interleukin 13 receptor, alpha 1 (Il13ra1) 58.3 128.9 1.1
Th1 cytokine
Tumor necrosis factor (Tnf) 14.1 50.4 1.9
Transforming growth factor, beta 1 (Tgfb1) 455 213 20.9
The AffymetrixH Mouse Genome 430 2.0 Array was employed to identify changes in the gene expression profile in the thymus of a 15 week old of Hexb
2/2FcRc
+/+
mouse. ‘Signal’ represents a measure of the relative abundance of a particular transcript. ‘Exp/Base signal Log ratio’ denotes the change in the expression level for a
transcript between Base group (15 week old Hexb
+/2FcRc
+/+ thymus) and the Experimental group (15 week old Hexb
2/2FcRc
+/+ thymus). This change is expressed as the
log2 ratio. A log2 ratio of 1 is equivalent to a fold Change of 2. Representative genes that function in the immune system are listed.
doi:10.1371/journal.pone.0012105.t001
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LSD such as twitcher mice, and feline GM1 gangliosidosis. It is
thought that the accumulation of GM2 induces neuronal cell
death in GM2 gangliosidosis. Various extra-neural organs also
contain many minor ganglioside components. In particular, the
thymus has been found to have a very complex and characteristic
spectrum of ganglioside species [37,38]. Gadola et al have
previously observed that glycolipids are stored in the thymus
[22]. In addition, Zhou et al. have reported that GM1, GM2,
GM3, and GT1b can induce apoptosis in thymocytes in vitro [18].
We have also confirmed in our experiments that GM2 enhances
thymic cell death, resulting in the formation of in vivo-like T cell
subpopulations in vitro (data not shown). However, we also found
that the apoptosis and necrosis of thymic cells is decreased in 15
week old Hexb
2/2FcRc
2/2 mice, although the accumulation levels
did not obviously differ from Hexb
2/2FcRc
+/+ mice (data not
shown). This result suggests that the Fc receptor plays a role in
thymic cell death in Hexb
2/2FcRc
+/+ mice. We have previously
detected the presence of anti-GM2 and anti-GA2 autoantibodies
in end stage Hexb
2/2FcRc
+/+ mice [10] and also other
autoantibodies such as anti-ssDNA (unpublished data), which
suggests the presence of polyclonal antibodies in Hexb
2/2FcRc
+/+
mice. In our present study, we observed the deposition of IgG on
T cell membranes (Fig. 4E). These findings suggest that an anti-T
cell autoantibody is produced during the last stages in Hexb
2/2
FcRc
+/+ mice and that an IgG-FcR mediated pathway plays a role
in the thymic involution seen in Hexb
2/2FcRc
+/+ mice.The
thymus from Hexb
2/2FcRc
+/+ mice older than 15 weeks showed
a marked increase in the percentage of macrophages, particularly
in the cortex (Fig. 5A, B). Additionally, these macrophages were
found to contain many nuclear particles in the cytoplasm. These
results are consistent with the findings of previous histological
experiments using H&E, TEM and TUNEL analyses. Mip-1a
which is an important molecule in the pathogenesis of Hexb
2/2
mice [39], is upregulated in the thymus of 15 week old Hexb
2/2
FcRc
+/+ mice. The evidence suggests therefore that the increase in
the number of macrophages is partly due events that occur
peripherally to the thymus.
To better understand the molecular basis of thymic involution,
we performed cDNA microarray analysis to identify the changes in
gene expression that accompanied involution in this gland. The
results revealed an upregulation of immune response associated
genes dominated by macrophages. A question that then emerged
was how the macrophages were activated at this stage. It is very
possible that enhanced cell death and/or the FcRc dependent
signaling pathway is involved in the mechanism. Further analysis is
needed to determine whether the FcRc pathway does contribute
to gene expression changes in the thymus. On the other hand,
prior to autoantibody production, FcRc independent pathways
may induce thymic alterations. In this regard, previous reports
have indicated that in the CNS of Hexb
2/2 mice, the
accumulation of undegraded glycolipids in glial cells might be a
trigger of pro-inflammatory cytokine/chemokine production
[8,40]. It has also been reported that the induction of Mip-1a
might coincide with the accumulation of N-acetylhexosaminyl
glycoconjugates due to a Hexb deficiency in glial cells [31]. It is also
known that macrophages accumulate considerable levels of
glycolipids within late endosomes/lysosomes during the onset of
Sandhoff disease [22].
We detected many vacuoles in the cytoplasm of thymic
macrophages, which we speculated to be lysosomal storage
(Fig. 4A). Moreover, Periodic acid-Schiff (PAS) positive glycocon-
Figure 6. CXCL13 expression is markedly increased in the thymus of the 15 week old Hexb
2/2FcRc
+/+ mouse. (A) The CXCL13 mRNA
levels in the thymus from each of the Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice at 11, 13 and 15 weeks of age were determined by
real-time RT-PCR and compared with the levels in the Hexb
+/2FcRc
+/+ mouse (mean 6 S.D.;n=3–8). *P,0.05. (B) The CXCL13 mRNA levels in the
thymus, spleen and lymph nodes from 15 weeks old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice was also measured using real-time
RT-PCR and compared with the levels in Hexb
+/2FcRc
+/+ mice (mean 6 S.D.; n=4–8). *P,0.05. (C) Thymus cryosections from 13 week old
Hexb
+/2FcRc
+/+, 15 week old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice were stained with CXCL13 antibodies and detected using
DAB. Arrows indicate CXCL13-positive cells. Scale bar, 50 mm. (D) Thymic cells from 15 week old Hexb
2/2FcRc
+/+ mice were cell sorted using MACS.
The CXCL13 mRNA levels in the CD11b
+ and CD11b
2 cell populations are expressed relative to the normalized CXCL13 levels in whole thymic cells
(mean 6 S.D.; n=4). *P,0.05.
doi:10.1371/journal.pone.0012105.g006
Thymic Alterations in SD Mice
PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12105jugates were found to accumulate in the cytoplasm of thymic
macrophages (data not shown). Previously, Kawane et al. found
that DNaseII-deficient mice developed a rheumatoid arthritis-like
disease [41] and concluded that, if macrophages cannot degrade
mammalian DNA from erythroid precursors and apoptotic cells,
they produce TNF-a, which activates synovial cells to produce
various cytokines, leading to the development of chronic
polyarthritis. DNaseII-deficient mice and Hexb
2/2FcRc
+/+ mice
have a common phenotype in which undegraded substances
accumulate in the macrophages. It has been postulated that a Toll-
like receptor independent pathway underlies the molecular
mechanism by which cells sense the DNA that has escaped from
degradation and initiate an autoimmune response. Other recent
reports suggest also that the NALP3 inflammasome senses
lysosomal damage as an endogenous ‘danger’ signal and thus
induces inflammation in many diseases [42–46]. The accumula-
tion of glycolipids within macrophages, and also following the
activation of the inflammasome, may therefore be related to the
gene expression changes we observe in the thymus of Hexb
2/2
FcRc
+/+ mice.
CXCL13, an upregulated gene in end stage Hexb
2/2FcRc
+/+
mice, was found to be specifically expressed in the thymus, and B1
cells were also detected at increased levels in the thymus (Fig. 6A,
B, 7). High expression of CXCL13 has been found previously in
many autoimmune diseases, such as myasthenia gravis [31],
multiple sclerosis [33], and in a model mouse of SLE [26], and is
considered to be associated with autoantibody production. We
have shown also in our previous study that a significant elevation
of serum antibody levels occurs in the terminal stages of Hexb
2/2
FcRc
+/+ mice of more than 14 weeks of age [10]. Thus, a high
expression of CXCL13 and infiltration of B1 cells in Hexb
2/2
FcRc
+/+ mice may be a reflection of autoantibody production.
Based on our current results, we propose a mechanism by which
thymic alterations occur in Hexb deficient mice as follows. The
apoptosis of immature T cells occurs normally in Hexb
2/2FcRc
+/+
mice and these apoptotic T cells are engulfed by macrophages.
However, macrophages cannot degrade the glycolipids from
apoptotic T cells in these animals because of their Hexb deficiency,
and thus accumulate these molecules in lysosomes. The macro-
phages are then activated and produce CXCL13, which promotes
chemotaxis toward B1 cells and thus leads to the development of
autoimmunity. Once autoantibodies against T cells are produced,
the storage of T cell-derived glycolipids by macrophages is
enhanced via the autoantibody-dependent phagocytosis of T cells.
Figure 7. Significant increase in the B1 and B2 cell number in the thymus of 15 week old Hexb
2/2FcRc
+/+ mouse. (A) Thymus
cryosections from 13 week old Hexb
+/2FcRc
+/+, 15 week old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice were stained with CD19
monoclonal antibodies and detected using the ABC method. The bottom panels show higher magnification images of the framed areas in the top
panels. Scale bars, 50 mm. (B) Thymic cells from 15 week old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2 mice were stained with FITC-CD5,
PE-B220 and PE-Cy5-CD19 antibodies and the percentages of the B cell subsets were determined by flow cytometry (mean 6 S.D.; n=6–9). *P,0.01.
doi:10.1371/journal.pone.0012105.g007
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the production of autoantibodies against neuronal cell antigens or
neuronal cell - T cell common antigens such as GA2. Deletion of
FcRc may thus prevent thymic involution by blocking the
autoantibody dependent phagocytosis of T cells and suppressing
specific gene expression. A reduction of the serum titer against
GM2 and GA2 in Hexb
2/2FcRc
2/2 mice [10] might be related to
thymic integrity. Further studies involving other factors, such as
functional testing of single lymphocytes and innate immunity, will
be needed to further our understanding of autoimmunity in GM2
gangliosidoses.
Materials and Methods
Animals
All mice used in this study were bred and housed under specific
pathogen-free (SPF) conditions. All mouse experiments were
approved by the Animal Committee at Yokohama City Univer-
sity. SD model mice (Hexb
2/2 mice; C57BL/66129/Sv back-
ground) were kindly provided by R. L. Proia (NIH, Bethesda, MD)
and were bred in a closed colony over 30 generations to inbreed
for C57BL/6- and 129/Sv-derived genes [4]. FcRc gene deficient
Hexb
2/2 mice (Hexb
2/2FcRc
2/2) were generated by described as
previously [10]. Each experiment utilized tissue from Hexb
+/2
FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2 FcRc
2/2 mice. All mice
were euthanized by inhalation of sevoflurane and the thymus in
each case was collected aseptically for further analysis.
Human thymus
A hematoxylin and eosin (H&E) stained slide of a human
thymus, dissected from an 11-month-old male with SD who was
autopsied at Kobe Children’s Hospital [47], was kindly loaned by
Dr. H. Itoh.
Histopathology
The mice were perfused with 10% buffered formalin (Sigma-
Aldrich Corp. St. Louis, MO) and processed for paraffin
embedding. Deparaffinized and rehydrated sections (4 mm) were
stained with H&E or used for immunostaining. Apoptosis was
detected via the in situ terminal deoxy nucleotidyl transferase-
mediated dUTP nick end labeling (TUNEL) method using an
ApopTagH kit (Millipore, Billerica, MA). For staining ionized
calcium binding adaptor molecule 1 (Iba-1), sections were treated
with antigen retrieval reagent and then incubated with rabbit anti-
Iba-1 antibody (Wako Pure Chemical Industries, Ltd., Osaka,
Japan) overnight at 4uC. The washed sections were incubated with
biotinylated anti-rabbit IgG antibody (Nichirei, Tokyo, Japan) and
subsequently incubated with horseradish peroxidase (HRP) labeled
streptavidin (Nichirei). The peroxidase reaction was visualized by
diaminobenzidine (DAB) and hydrogen peroxide. For frozen
sections, the thymus of each mouse were embedded in OCT
compound (Sakura Finetek, Torrance, CA) and quickly frozen in
dry ice. For the staining of CXCL13, frozen sections (7 mm) were
stained with goat anti-CXCL13 pAb (R&D Systems, Inc.,
Minneapolis, MN), followed by HRP labeled goat anti-rat IgG
(Nichirei). For the staining of CD19, frozen sections (7 mm) were
stained with Rat anti-CD19 mAb (6D5; Chemicon International,
inc., Temecula, CA), followed by HRP labeled goat anti-rat IgG
(Nichirei). For Transmission electron microscopy (TEM), thymic
tissues was prefixed with 2.5% glutaraldehyde (Merck & Co., Inc.,
Whitehouse Station, NJ) and postfixed with 1% osmium tetroxide
(Wako Pure Chemical). The samples were embedded in Epon 812
resin (TAAB Laboratories, Aldermaston, Berkshire, UK). Ultra-
thin sections were stained with uranyl acetate and lead citrate
(Wako Pure Chemical). Samples were observed with an H-7500
electron microscope (Hitachi, Tokyo, Japan).
Flow cytometry
The remaining thymus samples were gently mechanically
dispersed into PBS containing 3% fetal bovine serum (staining
buffer) and filtered through a BD Falcon
TM Cell Strainer (70 mm
pore size; BD Biosciences, Franklin, NJ) to produce single cell
suspensions and washed twice with staining buffer. Aliquots of
1610
6 thymic cells were incubated with PE-labeled anti-CD4
(GK1.5; eBioscience, Inc., San Diego, CA) and FITC-conjugated
anti-CD8 (53-7.6; eBioscience) mouse monoclonal antibodies
(mAbs). For three color staining, thymic cells were stained with
PE-labeled anti-B220/CD45R (RA3-6B2; BD Biosciences) and
FITC-conjugated anti-CD5 (53-7.3RRH; eBioscience) and PE-
Cy5 conjugated CD19 (MB19-1; eBioscience) mAbs. For the
staining of thymic macrophages, the thymic cells were stained with
anti-Iba1 (Wako Pure Chemical), followed by Alexa Fluor H-488
labeled anti-rabbit IgG (H+L) (Invitrogen, Carlsbad, CA). For the
detection of autoantibody deposition on T cells, thymic cells were
stained with Goat anti-mouse IgG (Southern Biotech, Birming-
ham, AL) followed by Alexa FluorH-488 labeled Donkey anti-Goat
IgG (H+L) (Invitrogen) and PE labeled anti-TCRb (H57-597;
eBioscience). Flow cytometric analysis was carried out using
FACScan
TM with CELLQuest
TM software (BD Biosciences) or
with FACS Canto II
TM with FACSDiva
TM software (BD
Biosciences).
cDNA microarray
Pooled thymic RNA samples were obtained from two 15 weeks
old Hexb
2/2 mice and two strain-matched, 15 weeks old Hexb
+/2
mice. cDNA were synthesized by GeneChip T7-Oligo(dT)
Promoter Primer Kit (Affymetrix, Inc, Santa Clara, CA) and
TaKaRacDNASynthesisKit(TaKaRa BioInc, Shiga,Japan)from
10 mg total RNA. Biotinylated cRNA were synthesized by IVT
Labeling Kit (Affymetrix).Followingfragmentation, 10 mg of cRNA
were hybridized for 16 hr at 45uC on GeneChip Mouse Genome
430 2.0 Array (Affymetrix) containing 45101 unique mouse genes.
GeneChips were washed and stained in the Affymetrix Fluidics
Station 450. GeneChips were scanned using GeneChip Scanner
3000 7G. Single Array Analysis were calculated by Microarray
Suite version 5.0 (MAS5.0) with Affymetrix default setting and
global scaling as normalization method. The trimmed mean target
intensity of each array was arbitrarily set to 500. Signals were
calculated using the One-Step Tukey’s Biweight Estimate which
yields a robust weighted mean. The signal log ratio was computed
using a one-step Tukey’s Biweight method by taking a mean of the
log ratios of the probe pair intensities across the two arrays. All data
is MIAME compliant and that the raw data has been deposited in
GEO.
Real-time RT-PCR
Total RNA was purified with TRIzol Reagent (Invitrogen). To
determine the high CXCL13-expressing cells, a magnetic cell
sorting system was used for the RNA preparation. Briefly, a 1610
6
thymic cell suspension from 15 week old Hexb
2/2FcRc
+/+ mice
was stained with CD11b MicroBeads (Miltenyi Biotec, Bergisch
Gladbach, Germany) and separated using an MS Column
(Miltenyi Biotec), and a MiniMACSH Separator (Miltenyi Biotec).
cDNA was synthesized from total RNA by reverse transcription
using a commercial cDNA synthesis kit (TaKaRa Bio Inc). cDNA
synthesized from 500 ng of total RNA was used as the template in
each reaction. The relative gene expression levels were determined
using the SYBRH Premix Ex Taq
TM II (TaKaRa Bio Inc). The
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factor-alpha (TNF-a) were obtained from TaKaRa Bio. The
primer set for macrophage inflammatory protein-1 alpha (Mip-1a)
has been described previously [31]. The primers used to amplify
Chemokine (C-X-C motif) ligand 13 (CXCL13) are 59-
TCTCTCCAGGCCACGGTATTCT-39 (forward, F) and, 59-
ACCATTTGGCACGAGGATTCAC (reverse, R) and for stro-
mal cell-derived factor 1 (SDF-1) are 59-GAGCCAACGTCAAG-
CATCTG-39 (F) and 59-CGGGTCAATGCACACTTGTC-39
(R). Rps18 was amplified in each reaction simultaneously as a
standard control. The fluorescence changes from each well were
monitored using an ABI PRISMH 7500 Sequence Detection
System (Perkin Elmer, Inc, Waltham, MA).
Statistical analysis
Statistical analysis was performed using the Student’s t test. A
95% confidence limit was taken as significant.
Supporting Information
Figure S1 Immunofluorescent analysis of GA2 and thymocyte,
for each thymus derived from Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+
and Hexb
2/2FcRc
2/2 mice. Frozen section of the thymus from 15
week old Hexb
+/2FcRc
+/+, Hexb
2/2FcRc
+/+ and Hexb
2/2FcRc
2/2
and 13 week old Hexb
2/2FcRc
+/+ mice were labeled GA2 with
Alexa FluorH-488, CD4 and CD8 with Alexa FluorH-594, and
nuclear with Hoechst 33258, respectively. Arrows indicate the
deposition of GA2 in the cytosol of the CD4/8 negative cells. Scale
bar, 20 mm.
Found at: doi:10.1371/journal.pone.0012105.s001 (0.43 MB
PDF)
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